secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caribou Biosciences, Inc. (CRBU)
CIK:        0001619856
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001619856-24-000050
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Caribou Biosciences stockholders elect three directors and ratify auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Elected Class III directors: Rachel Haurwitz (57.4M for), Dara Richardson-Heron (50.2M for), Natalie Sacks (50.2M for).
- Ratified Deloitte & Touche as independent auditor for FY 2024 with 73.0M votes for, 0.2M against.
- Broker non-votes of 13.6M shares on director elections; no broker votes on auditor ratification.
- Annual meeting held June 13, 2024; all proposals passed as recommended by the board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1619856/000161985624000050/0001619856-24-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1619856/000161985624000050/crbu-20240613.htm
  HTML page:      https://secwatch.observer/filing/0001619856-24-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer